2-Deoxy-lyxo-hexose

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 530805

CAS#: 6664-99-9

Description: 2-Deoxy-lyxo-hexose is a bioactive chemical.

Chemical Structure

img
2-Deoxy-lyxo-hexose
CAS# 6664-99-9
Instruction

Theoretical Analysis

MedKoo Cat#: 530805
Name: 2-Deoxy-lyxo-hexose
CAS#: 6664-99-9
Chemical Formula: C6H12O5
Exact Mass: 164.07
Molecular Weight: 164.157
Elemental Analysis: C, 43.90; H, 7.37; O, 48.73

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: 2-Deoxy-lyxo-hexose

IUPAC/Chemical Name: lyxo-Hexose, 2-deoxy-

InChi Key: VRYALKFFQXWPIH-HSUXUTPPSA-N

InChi Code: InChI=1S/C6H12O5/c7-2-1-4(9)6(11)5(10)3-8/h2,4-6,8-11H,1,3H2/t4-,5-,6-/m1/s1

SMILES Code: O=CC[C@H]([C@H]([C@@H](CO)O)O)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 164.16 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Li J, Hsu HC, Ding Y, Li H, Wu Q, Yang P, Luo B, Rowse AL, Spalding DM, Bridges SL Jr, Mountz JD. Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis. Arthritis Rheumatol. 2014 Sep;66(9):2368-79. doi: 10.1002/art.38711. PubMed PMID: 24838610; PubMed Central PMCID: PMC4146698.

2: Hess D, Klüfers P. Phenylboronic acid esters of the common 2-deoxy-aldoses. Carbohydr Res. 2011 Sep 27;346(13):1752-9. doi: 10.1016/j.carres.2011.05.031. Epub 2011 Jul 21. PubMed PMID: 21816393.

3: Abe T, Takahashi S, Suzuki N. Metabolic properties of astrocytes differentiated from rat neurospheres. Brain Res. 2006 Jul 26;1101(1):5-11. Epub 2006 Jun 15. PubMed PMID: 16781685.

4: Salinska E, Bourne RC, Rose SP. Reminder effects: the molecular cascade following a reminder in young chicks does not recapitulate that following training on a passive avoidance task. Eur J Neurosci. 2004 Jun;19(11):3042-7. PubMed PMID: 15182312.

5: Mikeska T, Nieger M, Mansikkamäki H, Daniels J, Kolter T. Crystal structures of O-acetylated 2-acylamino-2-deoxy-D-galactose derivatives. Carbohydr Res. 2003 Sep 26;338(20):2119-28. PubMed PMID: 14505880.

6: Chiocconi A, Marino C, Otal E, de Lederkremer RM. Photoinduced electron transfer and chemical alpha-deoxygenation of D-galactono-1,4-lactone. Synthesis of 2-deoxy-D-lyxo-hexofuranosides. Carbohydr Res. 2002 Nov 19;337(21-23):2119-26. PubMed PMID: 12433476.

7: Lucka L, Sel S, Danker K, Horstkorte R, Reutter W. Carcinoembryonic antigen-related cell-cell adhesion molecule C-CAM is greatly increased in serum and urine of rats with liver diseases. FEBS Lett. 1998 Oct 30;438(1-2):37-40. PubMed PMID: 9821955.

8: Hwang YH, Kohla G, Geilen CC, Paul C, Kannicht C, Grunow D, Pohlentz G, Egge H, Nuck R, Reutter W. Synthesis of 2-deoxy-D-galactose containing gangliosides in vivo. FEBS Lett. 1993 Jul 19;327(1):63-7. PubMed PMID: 8335096.

9: Nevado J, Navarro MA, Heredia CF. Galactose inhibition of the constitutive transport of hexoses in Saccharomyces cerevisiae. Yeast. 1993 Feb;9(2):111-9. PubMed PMID: 8465600.

10: Vermersch PS, Tesmer JJ, Quiocho FA. Protein-ligand energetics assessed using deoxy and fluorodeoxy sugars in equilibrium binding and high resolution crystallographic studies. J Mol Biol. 1992 Aug 20;226(4):923-9. PubMed PMID: 1518062.

11: Geilen CC, Kannicht C, Orthen B, Heidrich C, Paul C, Grunow D, Nuck R, Reutter W. Incorporation of the hexose analogue 2-deoxy-D-galactose into membrane glycoproteins in HepG2 cells. Arch Biochem Biophys. 1992 Jul;296(1):108-14. PubMed PMID: 1318686.

12: Gorman JA, Gorman JW, Koltin Y. Direct selection of galactokinase-negative mutants of Candida albicans using 2-deoxy-galactose. Curr Genet. 1992 Mar;21(3):203-6. PubMed PMID: 1563045.

13: Gorman JA, Chan W, Gorman JW. Repeated use of GAL1 for gene disruption in Candida albicans. Genetics. 1991 Sep;129(1):19-24. PubMed PMID: 1936958; PubMed Central PMCID: PMC1204565.

14: Barber AJ, Rose SP. Amnesia induced by 2-deoxygalactose in the day-old chick: lateralization of effects in two different one-trial learning tasks. Behav Neural Biol. 1991 Jul;56(1):77-88. PubMed PMID: 1867628.

15: Krug M, Jork R, Reymann K, Wagner M, Matthies H. The amnesic substance 2-deoxy-D-galactose suppresses the maintenance of hippocampal LTP. Brain Res. 1991 Feb 1;540(1-2):237-42. PubMed PMID: 2054616.

16: Richter P, Pohle W, Grecksch G, Smalla KH, Jork R, Matthies H. Enhanced development of morphine tolerance in rats treated with 2-deoxy-D-galactose. Psychopharmacology (Berl). 1991;104(2):279-83. PubMed PMID: 1876672.

17: Zamani MR, Bullock S. Effect of 2-deoxy-D-galactose on fucose incorporation into brain glycoproteins. Biochem Soc Trans. 1990 Jun;18(3):417-8. PubMed PMID: 2373225.

18: Bullock S, Potter J, Rose SP. Effects of the amnesic agent 2-deoxygalactose on incorporation of fucose into chick brain glycoproteins. J Neurochem. 1990 Jan;54(1):135-42. PubMed PMID: 2403432.

19: Rose SP, Jork R. Long-term memory formation in chicks is blocked by 2-deoxygalactose, a fucose analog. Behav Neural Biol. 1987 Sep;48(2):246-58. PubMed PMID: 3675519.

20: Jork R, Grecksch G, Matthies H. Impairment of glycoprotein fucosylation in rat hippocampus and the consequences on memory formation. Pharmacol Biochem Behav. 1986 Dec;25(6):1137-44. PubMed PMID: 3027716.